Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled studyStephen A. Harrison, M. Scott Harris, Sarah Browne et al.|Journal of Hepatology|2024Cited by 135